Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
What is Market Cap of Conduit Pharmaceuticals Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A market cap is $105.28M.
What is the 52-week high for Conduit Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A 52 week high is $25.00 as of September 06, 2025.
What is the 52-week low for Conduit Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A 52 week low is $9.80 as of September 06, 2025.
What is Conduit Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
Conduit Pharmaceuticals Inc - Ordinary Shares - Class A stock price today is $16.85.
What was Conduit Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
Conduit Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday was $16.99.
What is the PE ratio of Conduit Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A’s P/E ratio is 762.44.
What is the Price-to-Book ratio of Conduit Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A P/B ratio is 6.1788.
What is Conduit Pharmaceuticals Inc - Ordinary Shares - Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A's EBITDA is -124.64.
What is the 50-day moving average of Conduit Pharmaceuticals Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Conduit Pharmaceuticals Inc - Ordinary Shares - Class A 50-day moving average is $11.14.
How many employess does Conduit Pharmaceuticals Inc - Ordinary Shares - Class A has?
Conduit Pharmaceuticals Inc - Ordinary Shares - Class A has 7 employees.
